Alpha 2.0
Login Register
» Authors » Santiago Llorente

Santiago Llorente

Explore the profile of Santiago Llorente including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 45
Citations 212
Followers 0
Related Specialties
General Surgery
Allergy & Immunology
General Medicine
Top 10 Co-Authors
Manuel Muro
Alfredo Minguela
Francisco Boix
Carmen Botella
Rafael Alfaro
Isabel Legaz
Victor Jimenez-Coll
Helios Martinez-Banaclocha
Jose Antonio Galian
Maria Rosa Moya-Quiles
Published In
Hum Immunol
Nefrologia (Engl Ed)
Transplantation
Nefrologia
Transplant Proc
Affiliations
Soon will be listed here.
Recent Articles
1.
Early Monitoring of Donor-Derived Cell-Free DNA in Kidney Allograft Recipients Followed-Up for Two Years: Experience of One Center
Botella C, Galian J, Jimenez-Coll V, Fernandez-Gonzalez M, Morales F, Martinez-Gomez G, et al.
Life (Basel) . 2024 Nov; 14(11). PMID: 39598289
(1) Background: donor-derived circulating free DNA (dd-cfDNA), an innovative biomarker with great potential for the early identification and prevention of graft damage. (2) Methods: Samples were collected prospectively and the...
2.
Design, In Vitro Evaluation and In Vivo Biocompatibility of Additive Manufacturing Three-Dimensional Printing of β beta-Tricalcium Phosphate Scaffolds for Bone Regeneration
Llorente J, Junquera L, Gallego L, Perez-Basterrechea M, Suarez L, Llorente S
Biomedicines . 2024 May; 12(5). PMID: 38791011
The reconstruction of bone deficiencies remains a challenge due to the limitations of autologous bone grafting. The objective of this study is to evaluate the bone regeneration efficacy of additive...
3.
MicroRNAs as Potential Graft Rejection or Tolerance Biomarkers and Their Dilemma in Clinical Routines Behaving like Devilish, Angelic, or Frightening Elements
Legaz I, Jimenez-Coll V, Gonzalez-Lopez R, Fernandez-Gonzalez M, Alegria-Marcos M, Galian J, et al.
Biomedicines . 2024 Jan; 12(1). PMID: 38255221
Allograft rejection is a widespread complication in allograft recipients with chronic kidney disease. Undertreatment of subclinical and clinical rejection and later post-transplant problems are caused by an imperfect understanding of...
4.
Update of the recommendations on the management of the SARS-CoV-2 coronavirus pandemic (COVID-19) in kidney transplant patients
Lopez V, Mazuecos A, Villanego F, Lopez-Oliva M, Alonso A, Beneyto I, et al.
Nefrologia (Engl Ed) . 2023 Nov; 43(5):531-545. PMID: 37957107
SARS-CoV-2 infection (COVID-19) has had a significant impact on transplant activity in our country. Mortality and the risk of complications associated with COVID-19 in kidney transplant recipients (KT) were expected...
5.
Early Cytomegalovirus Reactivation in Renal Recipients Is Associated with High Levels of B Cell Maturation Antigen Transcript Expression Prior to Transplantation
Alfaro R, Rodriguez-Aguilar L, Llorente S, Jimenez-Coll V, Martinez-Banaclocha H, Galian J, et al.
Int J Mol Sci . 2023 Jul; 24(13). PMID: 37445668
Cytomegalovirus (CMV) infection is the most frequent infection episode in kidney transplant (KT) recipients. Reactivation usually occurs in the first three months after transplantation and is associated with higher cellular...
6.
Higher Expression of Activated CD8 T Lymphocytes (CD8CD25, CD8CD69 and CD8CD95) Mediate Early Post-Transplant Acute Tubular Injury in Kidney Recipients
Boix F, Jimenez-Coll V, Legaz I, Alfaro R, Moya-Quiles M, de la Pena-Moral J, et al.
Front Biosci (Landmark Ed) . 2023 Jul; 28(6):119. PMID: 37395036
Background: Acute kidney injury (AKI) is a leading cause of early post-transplant kidney damage. Furthermore, acute tubular necrosis (ATN) is appointed as the most prevalent form of AKI, a frequent...
7.
All That Glitters in cfDNA Analysis Is Not Gold or Its Utility Is Completely Established Due to Graft Damage: A Critical Review in the Field of Transplantation
Jimenez-Coll V, El Kaaoui El Band J, Llorente S, Gonzalez-Lopez R, Fernandez-Gonzalez M, Martinez-Banaclocha H, et al.
Diagnostics (Basel) . 2023 Jun; 13(12). PMID: 37370877
In kidney transplantation, a biopsy is currently the gold standard for monitoring the transplanted organ. However, this is far from an ideal screening method given its invasive nature and the...
8.
Monitoring of Serological, Cellular and Genomic Biomarkers in Transplantation, Computational Prediction Models and Role of Cell-Free DNA in Transplant Outcome
Jimenez-Coll V, Llorente S, Boix F, Alfaro R, Galian J, Martinez-Banaclocha H, et al.
Int J Mol Sci . 2023 Feb; 24(4). PMID: 36835314
The process and evolution of an organ transplant procedure has evolved in terms of the prevention of immunological rejection with the improvement in the determination of immune response genes. These...
9.
Clinical Significance of the Pre-Transplant CXCR3 and CCR6 Expression on T Cells In Kidney Graft Recipients
Alfaro R, Llorente S, Gonzalez-Martinez G, Jimenez-Coll V, Martinez-Banaclocha H, Galian J, et al.
Transplant Proc . 2023 Jan; 55(1):66-71. PMID: 36621349
Background: T cells play a fundamental role in the processes that mediate graft rejection, tolerance, and defense against infections. The CXCR3 and CCR6 receptors, highly expressed in Th1 (type 1...
10.
Patient and graft survival in pancreas transplant recipients: The EFISPAN study
Ventura-Aguiar P, Cabello M, Beneyto I, Navarro Cabello D, Tabernero G, Alonso A, et al.
Nefrologia (Engl Ed) . 2022 Dec; 43(1):133-143. PMID: 36494288
Introduction And Objectives: Graft outcomes in pancreas transplantation have improved in recent decades, but data are mainly derived from registries or prospective single-centre studies. This large epidemiological study was undertaken...